ConceptioArchiveClinicalTrials.gov
ClinicalTrials.govpublic full text

A Phase 1, Randomized, Blinded, Dose-escalation Study of rAAV1-PG9DP Recombinant AAV Vector Coding for PG9 Antibody in Healthy Male Adults.

International AIDS Vaccine Initiative · 2014
ClinicalTrials.gov · Datasets · License: Public Domain · 2014
Open Source ↗
aidshivhiv-infectionshiv-prevention
hiv infections, hiv, aids, hiv vaccine, hiv prevention, aav, pg9, interventional, phase1
This document is indexed with metadata only — full text is not available in the archive for this record. Open the official source ↗

Related documents

Record · ID 878809
Retrieved via Conceptio — every document is proof-bundled with source, license, and retrieval metadata.